Home / Import refusals / NUV-3852229-1/120002/1

FDA Import Refusal NUV-3852229-1/120002/1 — AstraZeneca Pharmaceuticals, LP

AstraZeneca Pharmaceuticals, LP — FEI 2517100

The FDA refused shipment NUV-3852229-1/120002/1 from AstraZeneca Pharmaceuticals, LP (United States) on November 4, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 179 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
179

Recent inspections

  • 1211584 (NAI Wed Jul 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1022686 (NAI Thu Aug 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895233 (VAI Wed Aug 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 788561 (NAI Mon Nov 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 737328 (VAI Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-0410784-2/10001/1 (Fri May 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0593779-1/20001/1 (Tue May 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-5525737-9/10001/1 (Fri Mar 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1544392-9/10001/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9333932-1/20001/1 (Thu Jan 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources